This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effects of Chlorpromazine, Reserpine, Pentylenetetrazol U. S. P., and Placebo on Eighty-Four Female Geriatric Patients in a State Hospital

DAVID B. ROBINSON, M.D.

AMA Arch Gen Psychiatry 1959;1(1):41-46.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Coincident with the increasing longevity of the general population, physicians are faced with the care of an increasing number of elderly patients with mental and emotional problems which are, in part, peculiar to the period of senescence. The problems of geriatric mental illness and senility are especially profound for the state hospitals.

In Minnesota in 1940 approximately 8% of the general population were 65 years of age or older. By 1955 an estimated 10% of the general population fell in the same age category. Whereas in 1940, 0.8% of persons more than 65 years of age in the state were in mental hospitals, by the year 1954-1955, 1.4% were in such institutions. Of all patients in the Minnesota state mental hospitals today, 37% are 65 years of age or older.¹ Similar figures are available on a nationwide scale.^2,3 In the face of this . . . [Full Text PDF of this Article]

Author Affiliations
Rochester, Minn.

Footnotes
Submitted for publication Sept. 1, 1958.

This study was made possible by funds granted by the Department of Welfare, State of Minnesota.

Read at the meeting of the Western Division of the American Psychiatric Association, Los Angeles, November, 1957.

Section of Psychiatry, Mayo Clinic and Mayo Foundation. The Mayo Foundation, Rochester, Minn., is a part of the Graduate School of the University of Minnesota.

Abridgment of thesis submitted by Dr. Robinson to the Faculty of the Graduate School of the University of Minnesota in partial fulfillment of the requirements for the degree of Master of Science in Psychiatry.

Drugs were provided by Smith, Kline & French Laboratories, Ciba Pharmaceutical Products, Inc., and Bilhuber-Knoll Corporation. Howard P. Rome, M.D. (Mayo Clinic) assisted in formulating and reviewing the project. Magnus c. Petersen, M.D. (Superintendent, Rochester State Hospital) helped in planning and conducting the study.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?